More Articles

Cancer drug shortages in the US Pharma News | Posted 10/11/2011

There is concern being expressed about the growing number of drug shortages among essential and lifesaving cancer drugs.

Battle rages over anti-thrombotic medicine Biosimilars/News | Posted 10/11/2011

Sandoz/Momenta are ahead again in the fight for the lucrative anticoagulants market in the US. According to IMS Health data enoxaparin sodium injection is the best-selling hospital medicine in the...

AstraZeneca settles patent dispute over Seroquel XR Generics/News | Posted 10/11/2011

In an out-of-court deal, AstraZeneca has agreed with Accord Healthcare, Handa Pharmaceuticals and Intas Pharmaceuticals that the latter can sell generic forms of the antipsychotic blockbuster Seroq...

Merck acquires follow-on Copaxone NBCD: determined to lead in MS Biosimilars/General | Posted 10/11/2011

Germany-based Merck already markets its own multiple sclerosis (MS) drug Rebif (interferon beta-1a) but suffered a major blow during 2011 when regulators on both sides of the Atlantic rejected...

Sun Pharma offers to buy remaining Taro shares Pharma News | Posted 10/11/2011

Taro Pharmaceutical Industries confirmed that it had received a letter on 19 October 2011 from Sun Pharma offering to buy all outstanding shares of Taro, not currently held by Sun Pharma, at a pric...

Generics will grab Parkinson’s disease market share Reports | Posted 10/11/2011

Overall sales for Parkinson’s disease drugs in seven major countries will decline slightly from US$2.7 billion in 2010 to US$2.6 billion in 2020 in France, Germany, Italy, Japan, Spain, the UK and...

Obama’s fresh attempts to ease drugs shortages in the US Pharma News | Posted 04/11/2011

Action by the PresidentPresident Barack Obama signed an executive order 31 October 2011 to address an escalating shortage of life-saving medicines, his newest effort to advance social and economic...

Translational research to uncover new uses for generics Generics/Research | Posted 04/11/2011

On the surface, generic compounds and translational medicines could not appear more different. However, in April 2011, the US National Institutes of Health (NIH) met with academic, governmental, an...